---
title: 'Integrated Analysis of Cell-Free DNA and Novel Protein Biomarkers for Stratification
  and Therapy Monitoring in Stage IV Pancreatic Cancer: A Preliminary Study'
date: '2025-01-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39795577/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250112170448&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Background: Given the poor prognosis of metastatic pancreatic adenocarcinoma
  (mPDAC), closer disease monitoring through liquid biopsy, most frequently based
  on serial measurements of cell-free mutated KRAS (KRAS^(mut) cfDNA), has become
  a highly active research focus, aimed at improving patients'' long-term outcomes.
  However, most of the available data show only a limited predictive and prognostic
  value of single-parameter-based methods. We hypothesized that a combined longitudinal
  analysis ...'
disable_comments: true
---
Background: Given the poor prognosis of metastatic pancreatic adenocarcinoma (mPDAC), closer disease monitoring through liquid biopsy, most frequently based on serial measurements of cell-free mutated KRAS (KRAS^(mut) cfDNA), has become a highly active research focus, aimed at improving patients' long-term outcomes. However, most of the available data show only a limited predictive and prognostic value of single-parameter-based methods. We hypothesized that a combined longitudinal analysis ...